BlackRock
VERA icon

BlackRock’s Vera Therapeutics VERA Stock Holding History

BlackRock’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247M Buy
5,747,760
+659,658
+13% +$24.6M ﹤0.01% 1667
2026
Q1 		$205M Buy
5,088,102
+262,583
+5% +$11.3M ﹤0.01% 1659
2025
Q4 		$244M Buy
4,825,519
+578,329
+14% +$20.5M ﹤0.01% 1551
2025
Q3 		$123M Buy
4,247,190
+81,650
+2% +$1.89M ﹤0.01% 1971
2025
Q2 		$98.1M Buy
4,165,540
+173,003
+4% +$3.89M ﹤0.01% 2060
2025
Q1 		$95.9M Buy
3,992,537
+51,051
+1% +$1.64M ﹤0.01% 2010
2024
Q4 		$167M Buy
3,941,486
+489,284
+14% +$21.7M ﹤0.01% 1769
2024
Q3 		$153M Buy
3,452,202
+114,530
+3% +$4.35M ﹤0.01% 1820
2024
Q2 		$121M Buy
3,337,672
+18,708
+0.6% +$742K ﹤0.01% 1913
2024
Q1 		$143M Buy
3,318,964
+564,070
+20% +$20.1M ﹤0.01% 1853
2023
Q4 		$42.4M Buy
2,754,894
+396,476
+17% +$5.04M ﹤0.01% 2584
2023
Q3 		$32.3M Buy
2,358,418
+188,284
+9% +$3.23M ﹤0.01% 2659
2023
Q2 		$34.8M Buy
2,170,134
+759,864
+54% +$6.86M ﹤0.01% 2699
2023
Q1 		$10.9M Buy
1,410,270
+534,386
+61% +$4.12M ﹤0.01% 3264
2022
Q4 		$16.9M Buy
875,884
+85,089
+11% +$1.54M ﹤0.01% 3120
2022
Q3 		$16.9M Buy
790,795
+73,761
+10% +$1.38M ﹤0.01% 3128
2022
Q2 		$9.76M Buy
717,034
+37,359
+5% +$652K ﹤0.01% 3516
2022
Q1 		$16M Buy
679,675
+224,575
+49% +$4.83M ﹤0.01% 3313
2021
Q4 		$12.2M Buy
455,100
+141,063
+45% +$3.12M ﹤0.01% 3557
2021
Q3 		$5.45M Buy
314,037
+313,444
+52,857% +$5.6M ﹤0.01% 3926
2021
Q2 		$8K Buy
+593
New +$9.21K ﹤0.01% 5352

Other funds holding VERA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock's VERA Position: Q2 2026 in Review

BlackRock increased its Vera Therapeutics (VERA) stake by 13% in Q2 2026, buying an estimated $24.6M and bringing the position to 5,747,760 shares worth $247M. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

BlackRock first reported a position in VERA in Q2 2021 and has held it in 21 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • BlackRock held 5,747,760 shares of Vera Therapeutics worth $247M as of Q2 2026.
  • BlackRock bought 659,658 Vera Therapeutics shares in Q2 2026, an estimated $24.6M.
  • Vera Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1667 holding.
  • BlackRock first reported a position in Vera Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.